Blake Martell

Cooley advised Battery Ventures, a global, technology-focused investment firm, and PageUp Group, a human resources and talent software company that had been majority owned by Battery, on the sale of PageUp to EQT Group.

Cooley advised Founders Fund, a venture capital firm investing in smart people solving difficult problems, as a co-lead investor in Anduril Industries’ $1.5 billion Series F funding round, which increased Anduril’s valuation to $14 billion.

Cooley advised Lacework, a data-driven cloud security company, on its definitive agreement to be acquired by Fortinet (Nasdaq: FTNT), the global cybersecurity leader driving the convergence of networking and security.

Cooley advised Delphix, a vendor of test data management software, on its acquisition by Perforce, a provider of solutions to enterprise teams requiring productivity, visibility and scale along the development life cycle.

Cooley advised COUR Pharmaceuticals, a clinical-stage biotechnology company focused on the development of first-in-class disease-modifying therapies designed to induce antigen-specific tolerance for immune-mediated diseases, on the close of its $105 million Series A financing.